Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 7675800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.

  1993cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide.

  1993cited by this paper
• Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events.

  1993cited by this paper
• delta-9-Tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Calmétte-Guérin-activated macrophages.

  1993cited by this paper
• Delta 9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells.

  1992cited by this paper
• Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.

  1992cited by this paper
• Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages.

  1992cited by this paper
• Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.

  1991cited by this paper
• Molecular cloning of a human cannabinoid receptor which is also expressed in testis.

  1991cited by this paper
• L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages.

  1990cited by this paper
• Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages.

  1990cited by this paper
• The interaction of Naegleria fowleri amoebae with murine macrophage cell lines.

  1990cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Marijuana and immunity: tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis.

  1990cited by this paper
• Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages.

  1990cited by this paper
• Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.

  1990cited by this paper
• Nucleotide sequence of a human cannabinoid receptor cDNA.

  1990cited by this paper
• Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.

  1989cited by this paper
• Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators.

  1989cited by this paper
• Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

  1988cited by this paper
• Determination and characterization of a cannabinoid receptor in rat brain.

  1988cited by this paper
• Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

  1988cited by this paper
• Plasma membrane-associated tumor necrosis factor. A non-integral membrane protein possibly bound to its own receptor.

  1988cited by this paper
• Inhibition of natural killer cell function by marijuana components.

  1988cited by this paper
• A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

  1988cited by this paper
• Nitric oxide: a cytotoxic activated macrophage effector molecule.

  1988cited by this paper
• Role of tumor necrosis factor in monocyte/macrophage tumor cytotoxicity in vitro.

  1987cited by this paper
• Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide.

  1987cited by this paper
• Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells

  1987cited by this paper
• Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.

  1987cited by this paper
• Synthesis of nitrite and nitrate in murine macrophage cell lines.

  1987cited by this paper
• Tetrahydrocannabinol‐Induced Suppression of Macrophage Spreading and Phagocytic Activity In Vitro

  1986cited by this paper
• Requirement for the continual presence of lipopolysaccharide for production of tumor necrosis factor by thioglycollate‐induced peritoneal murine macrophages

  1986cited by this paper
• Cellular effects of cannabinoids.

  1986cited by this paper
• delta-9-Tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse.

  1985cited by this paper
• Production of a cytotoxin from phorbol myristate acetate-treated human promyelocytes.

  1984cited by this paper
• Cellular interactions in thymus-dependent antibody responses.

  1982cited by this paper
• Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

  1982cited by this paper
• The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages.

  1981cited by this paper
• Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus

  1979cited by this paper
• Interactions between calf alveolar macrophages and parainfluenza-3 virus

  1977cited by this paper
• Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria

  1977cited by this paper

• Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data.

  2025cites this paper
• Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges

  2024cites this paper
• Cannabinoid receptor-2 expression in canine multicentric diffuse large B-cell lymphoma: An immunohistochemical, digital pathology and clinical analysis.

  2024cites this paper
• Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis

  2020cites this paper
• Cannabinoids as anticancer therapeutic agents

  2020cites this paper
• Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects

  2019cites this paper
• Up-regulation of TDAG51 is a dependent factor of LPS-induced RAW264.7 macrophages proliferation and cell cycle progression

  2016cites this paper
• Microglia activation states and cannabinoid system: Therapeutic implications.

  2016cites this paper
• Delta-9-Tetrahydrocannabinol (THC) Protects Partly against Demyelination by Modulating the Inflammatory Response: An In Vitro Study in Aggregating Brain Cell Cultures

  2012cites this paper
• Delta-9-Tetrahydrocannabinol (THC) Protects Partly againstDemyelination by Modulating the Inflammatory Response: An In VitroStudy in Aggregating Brain Cell Cultures

  2012cites this paper
• Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation

  2009cites this paper
• Cannabinoid Effects on NFkappaB Function in Microglial-Like Cells: Dual Mode of Action

  2009cites this paper
• MINI-SYMPOSIUM ON FOOD VULNERABILITY IN SOCIETY: Sentinal Chemical Messengers: Endocannabinoid signaling transcends pain

  2009cites this paper
• Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

  2008cites this paper
• Hu 210: a potent tool for investigations of the cannabinoid system.

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cites this paper
• Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells

  2006cites this paper
• Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

  2005cites this paper
• Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.

  2005cites this paper
• The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B).

  2004cites this paper
• Cannabinoids as neuroprotective agents in traumatic brain injury.

  2004cites this paper
• Therapeutic Potential of Cannabinoids in CNS Disease

  2003cites this paper
• The endocannabinoid system in invertebrates.

  2002cites this paper
• Effects of delta-9-tetrahydrocannabinol on human immune function and host defense.

  2002cites this paper
• Substance Abuse and HIV-gp 120 : Are Opiates Protective ?

  2002cites this paper
• Comparative biology of the endocannabinoid system possible role in the immune response.

  2000cites this paper
• Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor.

  2000cites this paper
• 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1.

  2000cites this paper
• Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.

  2000cites this paper
• Endocannabinoid immune and vascular signaling.

  2000cites this paper
• Effects of Cannabinoids on the Immune System and Central Nervous System

  1999cites this paper
• Effects of Marijuana on the Lung and its Defenses against Infection and Cancer

  1999cites this paper
• Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids.

  1999cites this paper
• Marijuana use and increased risk of squamous cell carcinoma of the head and neck.

  1999cites this paper
• Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release.

  1998cites this paper
• Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications.

  1998cites this paper
• Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release.

  1998cites this paper
• Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2*

  1997cites this paper
• Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release

  1997cites this paper
• Anandamide suppresses nitric oxide and TNF‐α responses to Theiler's virus or endotoxin in astrocytes

  1997cites this paper
• Marijuana and cocaine impair alveolar macrophage function and cytokine production.

  1997cites this paper
• Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.

  1997cites this paper
• Cannabinoid Receptors Are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes*

  1996cites this paper